Veracyte Announces Medicare Coverage for Its Afirma® Gene Expression Classifier for Improved Thyroid Nodule... (spicious for cancer. About Veracyt...)

Veracyte Announces Medicare Coverage for Its Afirma® Gene Expression Classifier for Improved Thyroid Nodule Diagnosis

Date:1/9/2012

spicious for cancer.

About Veracyte
Veracyte, Inc., based in South San Francisco, Calif., is pioneering the emerging field of molecular cytology, applying molecular biomarkers to cytology samples in order to improve disease diagnosis by clarifying indeterminate results obtained from current methods. The company aims to enable doctors to make more informed treatment decisions that improve patient care and provide cost savings to the healthcare system. The company utilizes rigorous science and an extensive, multicenter clinical program throughout discovery and development. Veracyte's first product – the Afirma Thyroid FNA Analysis – combines expert cytopathology assessment with the Afirma Gene Expression Classifier, a genomic test that clarifies inconclusive thyroid nodule results as benign or suspicious for cancer. The company is currently in the early biomarker discovery phase for lung cancer and interstitial lung diseases. Veracyte is privately held and funded by Domain Associates, Kleiner Perkins Caufield & Byers, TPG Biotech and Versant Ventures. For more information, visit www.veracyte.com.

SOURCE Veracyte, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related biology technology :

1. New Data Suggest Veracytes Molecular Test Improves Accuracy of Thyroid Nodule Diagnosis Using Fine Needle Aspirate (FNA) Samples
2. New Data Suggest Veracytes Afirma® Gene Expression Classifier Cost-Effectively Resolves Inconclusive Thyroid Nodule FNA Biopsy Results
3. China-Biotics, Inc. Announces Conference Call to Discuss First Quarter 2009 Financial Results
4. Odyssey Thera Announces Milestone Achievement in Pfizer Alliance
5. InNexus Biotechnology Announces Launch of Large Scale Primate Study of DXL625
6. Anesiva Announces Second Quarter 2008 Financial Results and Update
7. SGX Pharmaceuticals Announces Financial Results for the Three and Six Months Ended June 30, 2008
8. Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2008
9. China Sky One Medical, Inc. Announces Conference Call to Discuss Second Quarter 2008 Results
10. China Yingxia International, Inc. Announces Conference Call to Discuss Second Quarter 2008 Results
11. ThirdBiotech Announces Kemeta as Newest Sponsor

Post Your Comments:

(Date:6/18/2013)... This webinar will examine the ... promotion, and review the basic FDA regulations and ... apply these principles through real world case studies ... fundamentals on FDA regulations and guidance related to ... Assessing traditional and newer forms of promotional materials ...

(Date:6/18/2013)... THE WOODLANDS, Texas , June 18, 2013 ... LXRX ), a biopharmaceutical company focused on ... that John Northcott has joined the ... strategy, and operations. Mr. Northcott brings extensive commercial ... on-market commercialization across a variety of therapeutic areas. ...

(Date:6/18/2013)... Though health care jobs continued to be added ... Labor Statistics -- the increase was far below the calendar ... care jobs were added in home health care and outpatient ... jobs. Overall, the U.S. unemployment rate stayed flat at 7.6 ... that a total of just over 36,000 job cuts were ...

(Date:6/18/2013)... 18, 2013 PathoGenetix, Inc. ... for rapid bacterial strain typing, announced today that ... company as Vice President of Engineering. Dr. Luckey ... company’s RESOLUTION™ Microbial Genotyping System . The ... instrument, pathogen-specific assay kits, database and software, will ...

Breaking Biology Technology:Drug Advertising and Promotion Labeling: FDA Regulations, New Webinar Hosted by Xtalks 2 John Northcott Joins Lexicon as Vice President of Marketing, Commercial Strategy and Operations 2 John Northcott Joins Lexicon as Vice President of Marketing, Commercial Strategy and Operations 3 MedZilla Employment Report for June 2013 -- Jobs in Health Care Grow, But at Slower Pace 2 MedZilla Employment Report for June 2013 -- Jobs in Health Care Grow, But at Slower Pace 3 PathoGenetix Hires Technology Development VP for Resolution Microbial Genotyping System 2 PathoGenetix Hires Technology Development VP for Resolution Microbial Genotyping System 3

[0] Drug Advertising and Promotion Labeling: FDA Regulations, New Webinar Hosted by Xtalks [0] John Northcott Joins Lexicon as Vice President of Marketing, Commercial Strategy and Operations [0] MedZilla Employment Report for June 2013 -- Jobs in Health Care Grow, But at Slower Pace [0] PathoGenetix Hires Technology Development VP for Resolution Microbial Genotyping System

... March 21, 2011 ICAP Ocean Tomo ... medicinal nebulizer on March 31st at the ICAP Ocean ... The technology of this patent portfolio provides improvements to ... Recent technological advancements have triggered the use ...

... 2011 Reportlinker.com announces that a new market ... Global Nanobiotechnology Industry ... the worldwide markets for Nanobiotechnology in US$ Million ... Inorganic Nanoparticles, Nanocomposites, Nanostructured Materials & Membranes, Nanotubes ...

... VentiRx Pharmaceuticals, Inc., a biopharmaceutical company focused ... (TLR8) agonists and antagonists for the treatment of ... presentation of positive clinical results from its randomized, ... of allergic rhinitis. The results demonstrated statistically significant ...

ICAP Ocean Tomo Announces the Auction of an Improved Compact, Portable Nebulizer Developed and Patented by Tidal Air Reportlinker Adds Global Nanobiotechnology Industry VentiRx Pharmaceuticals Presents Positive Clinical and Pre-Clinical Data at American Academy of Allergy Asthma & Immunology Annual Meeting

(Date:6/17/2013)... 17, 2013How kids eat their food may turn out to ... a new study out of St. Michael,s Hospital. , ... found a significant association between poor eating habits in ... or "bad" cholesterol, putting them at risk for ... in the Canadian Medical Association Journal today. ...

(Date:6/17/2013)... foundations with more modern elements. Using this same approachbut ... Dietrich School of Arts and Sciences have designed a ... storage, and gas transport more efficient and at a ... issue of the Journal of the American Chemical ... builds upon Pitt Associate Professor of Chemistry Nathaniel Rosi,s ...

(Date:6/17/2013)... bacteria, and algae, is a common component of sugar-free ... the medical field it,s approved by the FDA ... used during surgery as a substance that opens the ... , Now Profs. Ehud Gazit and Daniel Segal of ... and the Sagol School of Neuroscience, along with their ...

Breaking Biology News(10 mins):Poor eating behaviors may put preschoolers at risk for later health problems 2 'Chemical architects' build materials with potential applications in drug delivery and gas storage 2 Artificial sweetener a potential treatment for Parkinson's disease 2

[0] Poor eating behaviors may put preschoolers at risk for later health problems [0] 'Chemical architects' build materials with potential applications in drug delivery and gas storage [0] Artificial sweetener a potential treatment for Parkinson's disease

... of antibiotics that followed it, streptococcus bacteria have remained ... reason: the superb evolutionary skills of this pathogen to ... published this week in Science , scientists from ... genome sequencing to identify the precise steps in the ...

... for its immunosuppressive functions could also point the way ... the Indiana University School of Medicine have reported. ... enzyme called SHP2, which plays an important role in ... mutations are also known to cause several types of ...

... This release is available in German . ... mammals. As defense against these herbivores they developed complex defense ... and a number of toxic chemical substances. For decades it ... incurs costs to the plants. Now, using a new method ...

Cached Biology News:New research traces evolutionary path of multidrug-resistant strep bacteria 2 New research traces evolutionary path of multidrug-resistant strep bacteria 3

New research traces evolutionary path of multidrug-resistant strep bacteria Antibiotic offers potential for anti-cancer activity Fast growth, low defense -- plants facing a dilemma

Glycerol-based mounting medium for immunofluorescence microscopy. Formulated to retard photobleaching of fluorochromes such as fluorescein and rhodamine. Product can also be used as a diluent for fl...

... an aqueous-based mounting medium designed for ... Gel/Mount is especially recommended when using ... FluoroBlue. It can also be used ... fluorescein (FITC), Rhodamine (TMRITC) and Texas ...

... Reagent A - Fixation medium Reagent B ... intended for fixing cells in suspension with ... with Reagent B. This procedure gives antibodies ... morphological scatter characteristics of the cells intact. ...

...

Biology Products:

Fluorescent Mounting Media from KPL Gel / Mount mounting medium - fluorescence from GeneTex LEUCOPERM Suspension fixation and permeabilization solution from GeneTex Mastercycler gradient from Eppendorf North America